{"domain":"sproutpharmaceuticals.com","status":"valid","tier":"listed","authority":46,"verified":false,"title":"Sprout Pharmaceuticals","summary":"Sprout Pharmaceuticals, Inc. is a US women's health pharmaceutical company based in Raleigh, North Carolina, founded and led by Cindy Eckert. Sprout makes Addyi (flibanserin), which in 2015 became the first FDA-approved treatment for low sexual desire (hypoactive sexual desire disorder, HSDD) in women. In December 2025 the FDA approved Addyi for postmenopausal women, making it the only FDA-approved treatment for HSDD in both premenopausal and postmenopausal women under 65. This is the corporate ","country":"US","country_source":"ip","publisher_country":null,"publisher_country_source":null,"hosting_country":"US","llms_txt":"https://www.sproutpharmaceuticals.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-20T09:58:36.900Z","agent_terms":null,"categories":["healthcare"],"capabilities":[],"inferred_tags":["addyi","flibanserin","hypoactive sexual desire disorder","womens health pharmaceutical","fda approval"],"audience":"mixed","agent_uses":["read_docs"],"language":"en","platform_generated":false,"agent_summary":"Sprout Pharmaceuticals, maker of Addyi (flibanserin) for women's low sexual desire; offers company news, FDA approval history, research and links to patient and","llms_txt_cached":"https://agentwebmap.com/v1/domain/sproutpharmaceuticals.com/llms.txt","agentic":"documentation","section_keys":["core-pages","key-announcements","optional","related-sites"],"section_partial":false,"section_indexed_at":"2026-10-23T14:10:04.071Z"}